Corticosteroid-eluting implants for the management of chronic rhinosinusitis with or without nasal polyps

References

• DeConde AS, Soler ZM. Chronic rhinosinusitis: epidemiology and burden of disease. Am J Rhinol Allergy. 2016 Mar;30(2):134–139. PMID: 26980394.
   PubMed Web of Science ®Google Scholar
• Xu X, Reitsma S, Wang D, et al. Highlights in the advances of chronic rhinosinusitis. Allergy. 2021 Nov;76(11):3349–3358. Epub 2021 Jun 9. PMID: 33948955.
   PubMed Web of Science ®Google Scholar
• Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 Mar;11(3):213–739. Erratum in: Int Forum Allergy Rhinol. 2022 Jul;12(7):974. PMID: 33236525.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020 Feb 20;58(Suppl S29):1–464. PMID: 32077450.
   Google Scholar
• Thomas WW, Harvey RJ, Rudmik L, et al. Distribution of topical agents to the paranasal sinuses: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2013 Sep;3(9):691–703. Epub 2013 May 31. PMID: 23729216.
   PubMed Web of Science ®Google Scholar
• Murr AH, Smith TL, Hwang PH, et al. Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent. Int Forum Allergy Rhinol. 2011 JanFeb;1(1):23–32. Epub 2011 8. Erratum in: Int Forum Allergy Rhinol. 2019 Aug;9(8):945. PMID: 22287304.
   PubMed Web of Science ®Google Scholar
• Marple BF, Smith TL, Han JK, et al. Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants. Otolaryngol Head Neck Surg. 2012 Jun;146(6):1004–1011. Epub 2012 Feb 1. PMID: 22301107.
   PubMed Web of Science ®Google Scholar
• Han JK, Marple BF, Smith TL, et al. Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis. Int Forum Allergy Rhinol. 2012 Jul;2(4):271–279. Epub 2012 May 1. PMID: 22550039.
   PubMed Web of Science ®Google Scholar
• Smith TL, Singh A, Luong A, et al. Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening. Laryngoscope. 2016 DecJul;126(12):2659–2664. Epub 2016 1. Erratum in: Laryngoscope. 2020 Mar;130(3):836. PMID: 27363723.
   PubMed Web of Science ®Google Scholar
• Luong A, Ow RA, Singh A, et al. Safety and effectiveness of a bioabsorbable steroid-releasing implant for the paranasal sinus ostia: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2018 Jan;144(1):28–35. Epub 2017 Nov 2. PMID: 29098299; PMCID: PMC5833592.
   PubMed Web of Science ®Google Scholar
• Singh A, Luong AU, Fong KJ, et al. Bioabsorbable steroid-releasing implants in the frontal sinus ostia: a pooled analysis. Int Forum Allergy Rhinol. 2019 Feb;9(2):131–139. Epub 2018 Nov 15. PMID: 30431709; PMCID: PMC6587788.
   PubMed Web of Science ®Google Scholar
• Shah VN, Pasick LJ, Benito DA, et al. Complications associated with propel mometasone furoate bioabsorbable drug-eluting sinus stents from 2012 to 2020. Am J Rhinol Allergy. 2022 Mar;36(2):185–190. Epub 2021 Aug 3. PMID: 34342518.
   PubMed Web of Science ®Google Scholar
• Ernst FR, Imhoff RJ, DeConde A, et al. Budget impact of a steroid-eluting sinus implant versus sinus surgery for adult chronic sinusitis patients with nasal polyps. J Manag Care Spec Pharm. 2019 Aug;25(8):941–950. Epub 2019 Mar 7. PMID: 30843454.
   PubMed Web of Science ®Google Scholar
• Javanbakht M, Saleh H, Hemami MR, et al. A corticosteroid-eluting sinus implant following endoscopic sinus surgery for chronic rhinosinusitis: a UK-Based cost-effectiveness analysis. Pharmacoecon Open. 2020 Dec;4(4):679–686. PMID: 32048233; PMCID: PMC7688856.
   PubMed Web of Science ®Google Scholar
• Rizzo JA, Rudmik L, Mallow PJ, et al. Budget impact analysis of bioabsorbable drug-eluting sinus implants following endoscopic sinus surgery. J Med Econ. 2016 Sep;19(9):829–835. Epub 2016 Apr 21. PMID: 27064315.
   PubMed Web of Science ®Google Scholar
• Wang C, Yu L, Chu X, et al. Short-term postoperative efficacy of steroid-eluting stents for eosinophilic chronic rhinosinusitis with nasal polyps: a randomized clinical trial. Int Forum Allergy Rhinol. 2022 Sep 9. Epub ahead of print. PMID: 36086876.
   Web of Science ®Google Scholar
• Huang Z, Zhou B, Wang D, et al. Comparison of bioabsorbable steroid-eluting sinus stents versus nasopore after endoscopic sinus surgery: a multicenter, randomized, controlled, single-blinded clinical trial. Ear Nose Throat J. 2022 May;101(4):260–267. Epub 2020 Aug 26. PMID: 32845808.
   PubMed Web of Science ®Google Scholar
• Han JK, Kd F, Smith TL, et al. RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis. Int Forum Allergy Rhinol. 2014 Nov;4(11):861–870. Epub 2014 Sep 29. PMID: 25266981.
   PubMed Web of Science ®Google Scholar
• Kd F, Han JK, Stolovitzky JP, et al. RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study. Int Forum Allergy Rhinol. 2016 Jun;6(6):573–581. Epub 2016 Mar 14. PMID: 26992115.
   PubMed Web of Science ®Google Scholar
• Kern RC, Stolovitzky JP, Silvers SL, et al. RESOLVE II study investigators. A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps. Int Forum Allergy Rhinol. 2018 Apr;8(4):471–481. Epub 2018 Jan 19. PMID: 29350840; PMCID: PMC5900893.
   PubMed Web of Science ®Google Scholar
• Douglas RG, Psaltis AJ, Rimmer J, et al. Phase 1 clinical study to assess the safety of a novel drug delivery system providing long-term topical steroid therapy for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019 Apr;9(4):378–387. Epub 2019 Jan 15. PMID: 30645028.
   PubMed Web of Science ®Google Scholar
• Cervin A, Rimmer J, Wrobel A, et al. Long-acting implantable corticosteroid matrix for chronic rhinosinusitis: results of LANTERN phase 2 randomized controlled study. Int Forum Allergy Rhinol. 2022 Feb;12(2):147–159. Epub 2021 Sep 17. PMID: 34534410; PMCID: PMC9292908.
   PubMed Web of Science ®Google Scholar
• LYR-210 & LYR-220 CLINICAL PROGRAMS KEY OPINION LEADER EVENT. https://investors.lyratherapeutics.com/static-files/c68619c3-35f9-4124-8c6d-e6c2d2c36694
   Google Scholar